Homeostasis
PrivateLast Round
Pre Seed
Mar 17, 2025
Total Funding Raised
$1.2M
Company Overview
Homeostasis operates in Energy & Sustainability and is based in Tacoma, Washington. Its latest recorded funding round was a Pre Seed round in March 2025.
Homeostasis is a materials company that develops electrochemical reactor technology to convert industrial carbon dioxide emissions into high-value synthetic graphite for energy storage and industrial applications.
Sector
Energy & Sustainability
Verticals
Advanced Materials, Carbon Capture, Clean Manufacturing, Energy Storage
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Homeostasis Comparables
Compare Homeostasis with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Maple Materials | 86% | |
| Saratoga Energy Corporation | 85% | |
| UP Catalyst | 81% |
For institutional investors. Book with your work email.
Homeostasis Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Homeostasis Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Kayak Ventures | Pre Seed |
| Washington State Department of Commerce | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 16, 2026
Grew 31% quarter-over-quarter, from 16 to 21 employees.
- Mar 17, 2025
$600K raised in Pre Seed round.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- receives_financingSep 9, 2026
In Aug '26, Homeostasis Systems Corp. receives $304K in Small Business Innovation Research grant financing from the U.S. National Science Foundation in Washington and an undisclosed private investment from Pachamama Ventures.
For institutional investors. Book with your work email.
Homeostasis Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Homeostasis's valuation, stock price, and market status.
Is Homeostasis a public or private company?
Homeostasis is a private company.
What is the current stock price of Homeostasis?
Homeostasis is a private company, so its shares have no public market price. Caplight tracks Homeostasis's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Homeostasis worth (valuation)?
Valuation information for Homeostasis is not publicly available.
Can I buy Homeostasis stock?
Homeostasis shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Homeostasis's last funding round?
Homeostasis's most recent funding round was Pre Seed on March 17, 2025.
Who are the main investors in Homeostasis?
Key investors in Homeostasis include Kayak Ventures, Washington State Department of Commerce.
Will Homeostasis IPO soon?
No public IPO plans have been announced for Homeostasis.
How can I track Homeostasis secondary market activity?
Caplight tracks bids, offers, and trades in Homeostasis's shares on secondary markets.